Pigments can restore more natural appearance that patients are happy with, study finds
How to recognize the symptoms of bipolar mania.
Bacteria found in plumbing may sicken thousands each year, study suggests
Small, preliminary study suggests oxytocin might ease 'ringing in the ears'
Study supports notion that the habit is toxic to brain cells, slows mental abilities
Pfizer will not split into two publicly traded companies, a decision that, at least for now, ends Wall Street speculation over the drugmaker's future. The company said Monday it believes it is best positioned ...
Pfizer said on Monday the decision would not have an impact on its 2016 financial forecast. The decision not to create two publicly traded companies follows the collapse of its planned $160 billion acquisition of Allergan Inc after a change in tax law took away the tax benefits of the deal. Investors were expecting the company to step back from the split, Sanford Bernstein analyst Tim Anderson said in a research note.
(Reuters) - Vela Diagnostics said its test for the Zika virus had received "emergency use authorization" from the U.S. Food and Drug Administration. The FDA issues such emergency use authorization during public health emergencies, to quickly deploy unapproved medical products for as long as they are needed. The regulator last month issued a similar authorization for a Zika diagnostics test from Swiss drugmaker Roche.